Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Amikacin measurement |
Component |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amikacin adverse reaction |
Causative agent (attribute) |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to amikacin |
Causative agent (attribute) |
False |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Serum amikacin measurement |
Component |
False |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Plasma amikacin measurement |
Component |
False |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amikacin 500mg/2mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
amikacine 100 mg/2 mL, pour injection pédiatrique |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amikacin sulfate 100mg/2mL powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amikacin sulfate 1gram/4mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amikacin 500mg/100mL infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amikacin 62.5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amikacin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amikacin sulfate (substance) |
Is a |
False |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Measurement of amikacin peak concentration |
Component |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Measurement of amikacin trough concentration (procedure) |
Component |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to amikacin |
Causative agent (attribute) |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing amikacin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amikacin desensitisation therapy |
Using substance (attribute) |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amikacin sulfate (substance) |
Is modification of (attribute) |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amikacin 500mg/100mL conventional release solution for infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amikacin (as amikacin sulfate) 100 milligram/2 milliliter conventional release solution for injection vial |
Has basis of strength substance (attribute) |
False |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amikacin (as amikacin sulfate) 500 milligram/2 milliliter conventional release solution for injection vial |
Has basis of strength substance (attribute) |
False |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amikacin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amikacin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amikacin (as amikacin sulfate) 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amikacin (as amikacin sulfate) 250 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amikacin liposome |
Is modification of (attribute) |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amikacin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amikacin only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amikacin (as amikacin sulfate) 125 mg/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amikacin (as amikacin sulfate) 5 mg/mL solution for infusion |
Has basis of strength substance (attribute) |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amikacin (as amikacin sulfate) 250 mg/mL solution for infusion and/or injection |
Has basis of strength substance (attribute) |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Plasma amikacin measurement |
Component |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Serum amikacin measurement |
Component |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only amikacin in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amikacin-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Amikacin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |